Comments for Question 12

----------------------------------------
QUESTION 12:
     After publication, should access include the deposit of
     biological materials as set forth in 37 CFR 1.802 et seq.?

----------------------------------------
FROM RESPONDENT 001:
     
     NAME:               David E. Craword, Jr. (Reg No. 38,118)
     COMPANY:            ROGERS, HOWELL & HAFERKAMP
                         COUNSELLORS AT LAW
     ADDR-1:             PIERRE LACLEDE CENTER, SUITE 1400
                         7733 F0RSYTH BOULEVARD
     CITY, STATE ZIP:    ST.LOUIS, MISS0URI 63105-1817
     TELEPHONE:          (314) 727-5188
     FAX:
     REPRESENT:          unclear
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     001-Q12.TXT
     Yes. A less than enabling disclosure defeats the goals of publishing
     the application in the first place. Omission of a biological material
     deposit causes a less than enabling disclosure.

----------------------------------------
FROM RESPONDENT 026:
     NAME: Louis Maassel 
     COMPANY: World Intellectual Property Organization, Geneva, Switzerland 
     ADDR-1: 12716 Buckingham Drive 
     CITY, STATE ZIP: Bowie, Maryland 20715
     TELEPHONE: 301) 464-4306
     FAX: 
     REPRESENT: self
     

----------------------------------------
COMMENT ON QUESTION 12:
     No comment.

----------------------------------------
FROM RESPONDENT 041:
     NAME: Frederick S. Burkhart 
     COMPANY: INTELLECTUAL PROPERTY LAW SECTION
       OF THE. STATE. BAR OF MICHIGAN 
     ADDR-1: 306 TOWNSEND STREET 
     CITY, STATE ZIP: LANSING, MICHIGAN 48933
     TELEPHONE: 517-372-9030
     FAX: 
     REPRESENT: association
     

----------------------------------------
COMMENT ON QUESTION 12:
     It is the understanding of this Committee that other countries which publish patent applications at 18 months allow access to the deposit of biological materials upon publication. In order to promot     e harmonization, the United States Patent and Trademark Office should adopt a compatible practice. 

----------------------------------------
FROM RESPONDENT 019:
     NAME:	Wilmot H. McCutchen, President
     COMPANY:	HOUSTON INVENTORS ASSOCIATION 
     ADDR-1:	
     CITY, STATE ZIP:	HOUSTON, TEXAS
     TELEPHONE:	(713) 957 4344
     FAX:	(713) 868-4104
     REPRESENT:	COMPANY
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     019-Q12.TXT
     Biological materials should not be made accessible to the public
     after publication without the express consent of the applicant, for
     the- reasons stated in response to Question 10 Our law forbids file
     access without consent 3S USC 122 Appendix "D"]

----------------------------------------
FROM RESPONDENT 010:
     NAME:	Scott Weide 
     COMPANY:	QUIRK & TRATOS 
     ADDR-1:	550 E. CHARLESTON BLVD. . SUITE D 
     CITY, STATE ZIP:	LAS VEGAS NEVADA 89104
     TELEPHONE:	(702) 386-1778
     FAX:	
     REPRESENT:	firm
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     010-Q12.TXT
     No. Such would be overly burdensome of the Patent Office and perhaps,
     the applicant.

----------------------------------------
FROM RESPONDENT 029:
     NAME:	Marcia H. Sundeen
     COMPANY:	PENNIE & EDMONDS 
     ADDR-1:	1701 Pennsylvania Avenue, N.W.
     CITY, STATE ZIP:	Washington, D.C. 20006-4706
     TELEPHONE:	(202) 393-0177
     FAX:	(202) 393 0462
     REPRESENT:	PTO Relations Committee
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     029-Q12.TXT
     Yes.

----------------------------------------
FROM RESPONDENT 033:
     NAME:	TOM EASTEP
     COMPANY:	THE ALLIANCE FOR AMERICAN INNOVATION 
     ADDR-1:	1100 Connecticut Ave. NW, Suite 1200
     CITY, STATE ZIP:	Washington, D.C 20036-4101
     TELEPHONE:	202-293-1414
     FAX:	202-467-5591
     REPRESENT:	ALLIANCE FOR AMERICAN INNOVATION
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     033-Q12.TXT
     YES.

----------------------------------------
FROM RESPONDENT 008:
     NAME: Gabriel P. Katona
     COMPANY: 	Schweitzer Cornman & Gross
     		Attorneys at Law
     ADDR-1:	230 Park Avenue
     CITY, STATE ZIP:	New York, New York 10169-0059
     TELEPHONE: (212) 986-3377
     FAX: (212) 986-6126
     REPRESENT: unclear
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     008-Q12.TXT
     Since the biological deposit is a part of the disclosure, it should
     be accessible on the basis of the depository information in the
     bibliographic details of the database I am not convinced that the
     depository information should be included in the OG publication or
     only in the application information in the database, because
     inclusion in the publication may represent further difficulties and
     possible delays in publication

----------------------------------------
FROM RESPONDENT 004:
     NAME:     Michael H. Minns
     COMPANY:  INGERSOLL-RAND COMPANY
               Patent Department
     ADDR-1:   942 Memorial Parkway
     CITY, STATE ZIP:    Phillipsburg, NJ 08865
     TELEPHONE:     (908)859-7700
     FAX: (908) 859-7707
     REPRESENT:     self
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     004-Q12.TXT
     No comment.

----------------------------------------
FROM RESPONDENT 025:
     NAME:	Yukiji Kobayashi, President
     COMPANY:	Japan Intellectual Property Association 
     ADDR-1:	Shintomi 1-chome Bld;. 7F 
     	9 8, Shintomi 1~chome 
     CITY, STATE ZIP:	Chuo~ku. TokYo 104, JAPAN 
     TELEPHONE:	813 3206 2243
     FAX:	81 3 3206 2230
     REPRESENT:	association
     

----------------------------------------
COMMENT ON QUESTION 12:
     -------
     025-Q12.TXT
     From the view point of publication of invention, it is theoretically
     conceivable that the biological material is open to furnishing as
     well at the time of publication of specification, but due to the
     special nature of biological material patent laws in Europe and in
     Japan limits furnishing at the time of publication of invention. It
     is desired that USPTO would do the same. (Response to your question
     #12)


Last Modified: March 1995